AeRang Kim

5.0k total citations
64 papers, 2.2k citations indexed

About

AeRang Kim is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, AeRang Kim has authored 64 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Neurology, 28 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in AeRang Kim's work include Neuroblastoma Research and Treatments (29 papers), Sarcoma Diagnosis and Treatment (22 papers) and Neurofibromatosis and Schwannoma Cases (21 papers). AeRang Kim is often cited by papers focused on Neuroblastoma Research and Treatments (29 papers), Sarcoma Diagnosis and Treatment (22 papers) and Neurofibromatosis and Schwannoma Cases (21 papers). AeRang Kim collaborates with scholars based in United States, United Kingdom and Australia. AeRang Kim's co-authors include Brigitte C. Widemann, Frank M. Balis, Elizabeth Fox, Karlyne M. Reilly, Douglas R. Stewart, David Viskochil, Markku Miettinen, Susan M. Blaney, Brenda J. Weigel and Diana Bradford and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Neurology.

In The Last Decade

AeRang Kim

61 papers receiving 2.2k citations

Peers

Countries citing papers authored by AeRang Kim

Since Specialization

Citations

This map shows the geographic impact of AeRang Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AeRang Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AeRang Kim more than expected).

Fields of papers citing papers by AeRang Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AeRang Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AeRang Kim. The network helps show where AeRang Kim may publish in the future.

Co-authorship network of co-authors of AeRang Kim

This figure shows the co-authorship network connecting the top 25 collaborators of AeRang Kim. A scholar is included among the top collaborators of AeRang Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AeRang Kim. AeRang Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma 2024 ·Journal of Clinical Oncology ·Paul A. Meyers, Noah Federman, Najat C. Daw, Peter M. Anderson, Lara E. Davis, AeRang Kim, Margaret E. Macy, (unknown), Ravin Ratan, Richard F. Riedel, Matteo Trucco, James B. Breitmeyer, Jeffrey A. Toretsky, Joseph A. Ludwig	13
2	Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas 2023 ·Neuro-Oncology ·Andrea M. Gross, Eva Dombi, Pamela L. Wolters, Andrea Baldwin, (unknown), (unknown), Staci Martin, Joanne Derdak, Kara Heisey, (unknown), Seth M. Steinberg, David Venzon, Michael J. Fisher, AeRang Kim, Miriam Bornhorst, Brian Weiss, Jaishri O. Blakeley, Malcolm A. Smith, Brigitte C. Widemann	44
3	Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II Trials 2023 ·The Oncologist ·Srivandana Akshintala, (unknown), Yao Lu, Karla V. Ballman, Scott M. Schuetze, Rashmi Chugh, Robert G. Maki, Denise K. Reinke, Brigitte C. Widemann, AeRang Kim	13
4	Emerging hyperthermia applications for pediatric oncology 2020 ·Advanced Drug Delivery Reviews ·(unknown), Karun Sharma, AeRang Kim, Pavel Yarmolenko	17
5	High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy 2019 ·Clinical Cancer Research ·Avinash Eranki, Priya Srinivasan, Mario Ries, AeRang Kim, Christopher A. Lazarski, Christopher Rossi, Tatiana D. Khokhlova, Emmanuel Wilson, Susan M. Knoblach, Karun Sharma, Bradford J. Wood, Chrit Moonen, Anthony D. Sandler, Peter C.W. Kim	137
6	Magnetic Resonance Imaging–guided High-intensity Focused Ultrasound Applications in Pediatrics 2018 ·Topics in Magnetic Resonance Imaging ·Karun Sharma, Pavel Yarmolenko, Avinash Eranki, Ari Partanen, Haydar Çelik, AeRang Kim, Matthew E. Oetgen, Peter C.W. Kim	11
7	Comparison of Noninvasive High-Intensity Focused Ultrasound with Radiofrequency Ablation of Osteoid Osteoma 2017 ·The Journal of Pediatrics ·Karun Sharma, Pavel Yarmolenko, Haydar Çelik, Avinash Eranki, Ari Partanen, (unknown), AeRang Kim, Matthew E. Oetgen, (unknown), (unknown), Peter Kim	41
8	Boiling histotripsy lesion characterization on a clinical magnetic resonance imaging-guided high intensity focused ultrasound system 2017 ·PLoS ONE ·Avinash Eranki, Navid Farr, Ari Partanen, Karun Sharma, Hong Chen, Christopher Rossi, Satya V. V. N. Kothapalli, Matthew E. Oetgen, AeRang Kim, Ayele H. Negussie, David L. Woods, Bradford J. Wood, Peter C.W. Kim, Pavel Yarmolenko	35
9	Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1—a consensus overview 2017 ·Human Pathology ·Markku Miettinen, Cristina R. Antonescu, Christopher D.�M. Fletcher, AeRang Kim, Alexander J. Lazar, Martha Quezado, Karlyne M. Reilly, Anat Stemmer‐Rachamimov, Douglas R. Stewart, David Viskochil, Brigitte C. Widemann, Arie Perry	216
10	The promise of signal transduction in genetically driven sarcomas of the nerve 2017 ·Experimental Neurology ·AeRang Kim, Christine A. Pratilas	14
11	Pediatric oncology enters an era of precision medicine 2017 ·Current Problems in Cancer ·Nita L. Seibel, Katherine A. Janeway, Carl E. Allen, Susan Chi, Yoon-Jae Cho, Julia Glade Bender, AeRang Kim, Theodore W. Laetsch, Meredith S. Irwin, Naoko Takebe, James V. Tricoli, D. Williams Parsons	34
12	Foley Catheter as a Vaginal Stent in a Toddler with Vaginal Rhabdomyosarcoma 2017 ·Journal of Pediatric and Adolescent Gynecology ·(unknown), Pranshu Mohindra, AeRang Kim, Veronica Gomez‐Lobo	5
13	Rhabdomyosarcoma of the head and neck in children: Review and update 2015 ·International Journal of Pediatric Otorhinolaryngology ·Brian K. Reilly, AeRang Kim, María T. Peña, Tiffany Dong, Christopher Rossi, Jonathan Murnick, Sukgi S. Choi	46
14	A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report 2012 ·Clinical Cancer Research ·Brigitte C. Widemann, AeRang Kim, Elizabeth Fox, Sylvain Baruchel, Peter C. Adamson, Ashish M. Ingle, Julia Glade Bender, Michael Burke, Brenda J. Weigel, Diana Stempak, Frank M. Balis, Susan M. Blaney	90
15	Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia 2012 ·Clinical Cancer Research ·Cody J. Peer, Tristan M. Sissung, AeRang Kim, Lokesh Jain, Sukyung Woo, Erin R. Gardner, C. Tyler Kirkland, Sarah Troutman, Bevin C. English, Emily D. Richardson, Joel D. Federspiel, David Venzon, William L. Dahut, Elise C. Kohn, Shivaani Kummar, Robert Yarchoan, Giuseppe Giaccone, Brigitte C. Widemann, William D. Figg	108
16	Bone mineral density in children and young adults with neurofibromatosis type 1 2012 ·Endocrine Related Cancer ·Maya Lodish, (unknown), Ninet Sinaii, Ethan Bornstein, AeRang Kim, (unknown), Andrea Baldwin, James C. Reynolds, Eva Dombi, Constantine A. Stratakis, Brigitte C. Widemann	20
17	Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas 2012 ·Pediatric Blood & Cancer ·AeRang Kim, Eva Dombi, (unknown), Elizabeth Fox, Staci Martin, Pamela L. Wolters, Frank M. Balis, Nalini Jayaprakash, Barış Türkbey, Naira Muradyan, Peter L. Choyke, Alyssa Reddy, Bruce R. Korf, Brigitte C. Widemann	55
18	Preclincial testing of Sorafenib and RAD001 in the Nf^flox/flox;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging 2011 ·Pediatric Blood & Cancer ·Jianqiang Wu, Eva Dombi, Edwin Jousma, R. Scott Dunn, Diana M. Lindquist, Beverly Schnell, Mi‐Ok Kim, AeRang Kim, Brigitte C. Widemann, Timothy P. Cripe, Nancy Ratner	48
19	The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates 2010 ·Investigational New Drugs ·AeRang Kim, (unknown), Rafael Pereira da Cruz, Diane E. Cole, Elizabeth Fox, Frank M. Balis, Brigitte C. Widemann	19
20	The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors 2008 ·Pediatric Blood & Cancer ·AeRang Kim, Lingyun Ji, Casilda Balmaceda, Blanca Diez, Stewart J. Kellie, Ira J. Dunkel, Sharon L. Gardner, Richard Sposto, Jonathan L. Finlay	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact